In a report released today, Leland Gershell from Oppenheimer reiterated a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report),
Category: Healthcare
H.C. Wainwright Reiterates Their Buy Rating on Fortress Biotech (FBIO)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Fortress Biotech (FBIO – Research Report) today and set a
Durect Corp (DRRX) Gets a Buy Rating from H.C. Wainwright
In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Durect Corp (DRRX – Research
Viking Therapeutics (VKTX) Received its Third Buy in a Row
After William Blair and Maxim Group gave Viking Therapeutics (NASDAQ: VKTX) a Buy rating last month, the company received another
Inovio Pharmaceuticals (INO) Received its Third Buy in a Row
After Cantor Fitzgerald and Maxim Group gave Inovio Pharmaceuticals (NASDAQ: INO) a Buy rating last month, the company received another
Alkermes (ALKS) Gets a Buy Rating from J.P. Morgan
In a report released yesterday, Cory Kasimov from J.P. Morgan maintained a Buy rating on Alkermes (ALKS – Research Report),
Cantor Fitzgerald Thinks Supernus Pharmaceuticals’ Stock is Going to Recover
Cantor Fitzgerald analyst Matthew Lillis reiterated a Buy rating on Supernus Pharmaceuticals (SUPN – Research Report) yesterday and set a